Home/Pipeline/Implantable Ports Market Expansion

Implantable Ports Market Expansion

Vascular Access for Chemotherapy/Chronic Therapy

CommercialActive

Key Facts

Indication
Vascular Access for Chemotherapy/Chronic Therapy
Phase
Commercial
Status
Active
Company

About Districlass Medical

Districlass Medical is a private, revenue-generating French medtech firm established in 2005, with a core focus on implantable ports for chemotherapy. It holds a strong position in the European market and is actively seeking distribution partnerships to expand into key English-speaking markets like the USA, Canada, the UK, and Australia. The company's product portfolio also includes specialized catheters, an adjustable gastric prosthesis, and pleural brushes, indicating a niche focus on chronic care and oncology support devices.

View full company profile